UPDATE: Chardan Capital Markets Starts Clovis Oncology (CLVS) at 'Sell' With Price Target of $15
Tweet Send to a Friend
(Updated - October 25, 2016 8:28 AM EDT)
Chardan Capital Markets initiated coverage on Clovis Oncology (NASDAQ: CLVS) with ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Chardan Capital Markets initiated coverage on Clovis Oncology (NASDAQ: CLVS) with ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
